Oric Pharmaceuticals Inc
NASDAQ:ORIC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oric Pharmaceuticals Inc
NASDAQ:ORIC
|
US |
|
A
|
Airbus SE
F:AIR
|
NL |
|
E
|
EQT AB
OTC:EQBBF
|
SE |
|
A
|
Arrow Electronics Inc
XMUN:ARW
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Oric Pharmaceuticals Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Oric Pharmaceuticals Does
ORIC Pharmaceuticals is a clinical-stage drug developer focused on medicines for cancer and other serious diseases. Its main job is to discover and test new small-molecule therapies that target the biological pathways tumors use to grow, survive treatment, and become resistant to existing drugs.
- Headquarters
- United States of America US
- Employees
- 104
- IPO date
- Apr 24, 2020